|
0
|
|
Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study.
(linkinghub.elsevier.com)
|
Heath PT
…
Madhi SA
Lancet Infectious Diseases
2026-05-01
|
#infection
#vaccination
#pregnancy
#immunogenicity
#safety
|
|
0
|
|
The promises and challenges of neoantigen cancer vaccines.
(nature.com)
|
Ott PA
Nature Biotechnology
2026-05-01
|
#vaccination
#cancer
#rna
#epitope
#immunogenicity
|
|
0
|
|
Global vaccine development.
(nature.com)
|
Kim JH
…
Ndembi N
Nature Medicine
2026-05-01
|
#vaccination
#immunity
#immunogenicity
|
|
0
|
|
Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study.
(linkinghub.elsevier.com)
|
Kone M
…
Sagara I
Lancet Infectious Diseases
2026-05-01
|
#vaccination
#malaria
#transmission
#immunogenicity
#adjuvant
|
|
0
|
|
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Leitner DR
…
Waldor MK
Lancet Infectious Diseases
2026-05-01
|
#vaccination
#immunogenicity
#safety
#attenuation
#cholera
|